Calabresi, PA
29  Ergebnisse:
Personensuche X
?
1

The genetic diversity of multiple sclerosis risk among Hisp..:

Beecham, AH ; Amezcua, L ; Chinea, A...
Multiple Sclerosis Journal.  26 (2019)  11 - p. 1329-1339 , 2019
 
?
2

Therapeutic Application of Monoclonal Antibodies in Multipl..:

Orthmann‐Murphy, JL ; Calabresi, PA
Clinical Pharmacology & Therapeutics.  101 (2016)  1 - p. 52-64 , 2016
 
?
3

Quality control for retinal OCT in multiple sclerosis: vali..:

Schippling, S ; Balk, LJ ; Costello, F...
Multiple Sclerosis Journal.  21 (2014)  2 - p. 163-170 , 2014
 
?
 
?
5

Proof of concept studies for tissue-protective agents in mu..:

Mehta, LR ; Schwid, SR ; Arnold, DL...
Multiple Sclerosis Journal.  15 (2009)  5 - p. 542-546 , 2009
 
?
6

Vitamin D status and effect of low-dose cholecalciferol and..:

Hiremath, GS ; Cettomai, D ; Baynes, M...
Multiple Sclerosis Journal.  15 (2009)  6 - p. 735-740 , 2009
 
?
 
?
8

The utility of MRI in suspected MS: report of the Therapeut..:

Frohman, EM ; Goodin, DS ; Calabresi, PA...
American Journal of Ophthalmology.  137 (2004)  2 - p. 390-391 , 2004
 
?
 
?
10

Spotlight on Trans-Synaptic Degeneration in the Visual Path..:

Filippatou AG ; Calabresi PA ; Saidha S.
https://www.dovepress.com/spotlight-on-trans-synaptic-degeneration-in-the-visual-pathway-in-mult-peer-reviewed-fulltext-article-EB.  , 2023
 
?
12

Optical coherence tomography in multiple sclerosis: A 3-yea..:

Paul, F ; Calabresi, PA ; Barkhof, F...
https://discovery.ucl.ac.uk/id/eprint/10138873/9/Barkhof_Optical%20coherence%20tomography%20in%20multiple%20sclerosis-%20A%203-year%20prospective%20multicenter%20study_AOP.pdf.  , 2021
 
?
14

The APOSTEL 2.0 Recommendations for Reporting Quantitative ..:

Aytulun, A ; Cruz-Herranz, A ; Aktas, O...
https://discovery.ucl.ac.uk/id/eprint/10127331/1/WNL.0000000000012125.full.pdf.  , 2021
 
1-15